US › Healthcare

Airsculpt Technologies Inc (AIRS)

US · Healthcare · Medical Care Facilities

$0.53-62.92%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

$42.9M

Revenue YoY

-2.5%

Net profit

$-1.1M

EPS

$-0.02

EPS estimate

$0.02

Net margin

-2.6%

EPS came in at -0.02 against a street estimate of 0.02 — a miss of 200.0%.

Key statistics

Market cap

$103.8M

Forward P/E

0.0

P/B

1.13

Book value

$1.47

EPS (TTM)

$-0.17

52-week high

$6.70

52-week low

$0.52

50-day MA

$1.94

200-day MA

$3.11

Beta

2.28

Analyst view

Analysts rate Airsculpt Technologies Inc a hold (1 buy, 2 hold, 0 sell out of 3) with an average price target of $4.50.

Shareholding

Insiders

42.22%

Institutions

61.66%

Largest institutional holders

Fund	Stake
Thrivent Financial For Lutherans	6.14%
BlackRock Inc	1.77%
Wexford Capital LP	1.17%
UBS Group AG	1.10%
FourWorld Capital Management LLC	1.04%
F.L.Putnam Investment Management	0.96%
AQR Capital Management LLC	0.65%
Geode Capital Management, LLC	0.63%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Airsculpt Technologies Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.